Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Atypical
protein kinase C zeta
(
PKCzeta
) is known to transduce signals that influence cell proliferation and survival. Here we show that recombinant human caspases can process
PKCzeta
at three sites in the hinge region between the regulatory and catalytic domains. Caspase-3, -6, -7, and -8 chiefly cleaved human
PKCzeta
at EETD downward arrowG, and caspase-3 and -7 also cleaved
PKCzeta
at DGMD downward arrowG and DSED downward arrowL, respectively. Processing of
PKCzeta
expressed in transfected cells occurred chiefly at EETD downward arrowG and DGMD downward arrowG and produced carboxyl-terminal polypeptides that contained the catalytic domain. Epitope-tagged
PKCzeta
that lacked the regulatory domain was catalytically active following expression in HeLa cells. Induction of apoptosis in HeLa cells by tumor necrosis factor alpha plus cycloheximide evoked the conversion of full-length epitope-tagged
PKCzeta
to two catalytic domain polypeptides and increased
PKCzeta
activity. A caspase inhibitor, zVAD-fmk, prevented epitope-tagged
PKCzeta
processing and activation following the induction of apoptosis. Induction of apoptosis in rat parotid C5 cells produced catalytic domain polypeptides of endogenous
PKCzeta
and increased
PKCzeta
activity. Caspase inhibitors prevented the increase in
PKCzeta
activity and production of the catalytic domain polypeptides. Treatment with lactacystin, a selective inhibitor of the proteasome, caused
polyubiquitin
-
PKCzeta
conjugates to accumulate in cells transfected with the catalytic domain or full-length
PKCzeta
, or with a
PKCzeta
mutant that was resistant to caspase processing. We conclude that caspases process
PKCzeta
to carboxyl-terminal fragments that are catalytically active and that are degraded by the ubiquitin-proteasome pathway.
...
PMID:Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. 1101 47
Patients with Wilson's disease (WD), Indian childhood cirrhosis (ICC), and idiopathic copper toxicosis (ICT) develop severe liver disease morphologically characterized by ballooning of hepatocytes, inflammation, cytoskeletal alterations, and Mallory body (MB) formation, finally leading to mostly micronodular cirrhosis. The pathogenesis of MBs in copper toxicosis is still unresolved. Immunohistochemical analysis of MBs in different types of copper intoxication revealed that keratin, p62, and ubiquitin are integral components. Thus MBs associated with copper intoxication resemble those present in alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH). p62 is a multifunctional immediate early gene product that, on the one hand, is involved in stress-induced cell signaling (particularly that of oxidative stress) by acting as an adapter protein linking receptor-interacting protein (RIP) with the
atypical protein kinase C
. On the other hand, p62 binds with high affinity to
polyubiquitin
and ubiquitinated proteins. In conclusion, p62 accumulation in WD, ICC, and ICT and deposition in MBs indicates a central role of protein misfolding induced by oxidative stress in copper-induced liver toxicity. By sequestering potentially harmful misfolded ubiquitinated proteins as inert cytoplasmic inclusion bodies (e.g., as MBs), p62 may be a major player in an important cellular rescue mechanism in oxidative hepatocyte injury.
...
PMID:Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. 1505
NGF (nerve growth factor) binding to TrkA (tropomyosin receptor kinase A) induces dimerization, autophosphorylation and internalization of the receptor to signalling vesicles for delivery of differentiation signals. TrkA interacts with p75 receptor through the p62-TRAF-6 (tumour-necrosis-factor-receptor-associated factor 6) complex bridging the two receptors. The
atypical protein kinase C
is activated and recruited to the receptor complex as well. TrkA is Lys63-polyubiquitinated on Lys485 by the E3 (ubiquitin ligase), TRAF-6, and E2 (ubiquitin-conjugating enzyme), UbcH7. Inhibition of polyubiquitination has been observed to interrupt signalling and internalization. Furthermore, an absence of p62 prevents endosomal localization and signalling. Altogether, these findings reveal Lys63-linked
polyubiquitin
chains and the shuttling protein p62 co-ordinately regulate TrkA internalization, trafficking and sorting.
...
PMID:The role of ubiquitin in neurotrophin receptor signalling and sorting. 1705 91